Dacheng Advises Xiamen Zeesan Biotech Co., Ltd. on NEEQ Listing
On December 9, 2014, Xiamen Zeesan Biotech Co., Ltd. (“Zeesan Biotech”, stock code: 831425) was successfully listed on the National Equities and Exchange Quotations (“NEEQ”) system.
A Xiamen-based team led by Guo Zhiqing, head of the capital markets department of the office, provided comprehensive legal counsel for Zeesan Biotech. The team also included associate Yu Xianju and trainee Peng Yanting. Their expertise was unanimously recognized by the client and participating intermediaries.
Zeesan Biotech, located in Xiamen National Torch Hi-tech Industrial Development Zone, is a hi-tech enterprise primarily engaged in the development, manufacture and sale of IVD reagents and equipment. It is the first NEEQ-listed enterprise advised by the Xiamen office.
A Xiamen-based team led by Guo Zhiqing, head of the capital markets department of the office, provided comprehensive legal counsel for Zeesan Biotech. The team also included associate Yu Xianju and trainee Peng Yanting. Their expertise was unanimously recognized by the client and participating intermediaries.
Zeesan Biotech, located in Xiamen National Torch Hi-tech Industrial Development Zone, is a hi-tech enterprise primarily engaged in the development, manufacture and sale of IVD reagents and equipment. It is the first NEEQ-listed enterprise advised by the Xiamen office.